We need a new paradigm for addiction that puts psychology first and recognizes its heterogeneity. Only then will we see that ...

Elyse Stevens had a reputation for taking on complex medical cases. People who'd been battling addiction for decades. Chronic ...

Addiction is one of the most intensely studied conditions in modern medicine, yet even with high‑resolution brain scans and ...

How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have reduced the opioid epidemic’s toll. Credit...Photo illustration by Ben Denzer ...

Researcher Victor DeNoble will speak on the biology of addiction and the brain at 7 p.m. Wednesday in the Copper Lounge at Montana Tech and 7 p.m. Thursday in the Lewis-Clark Room at the University of ...

We don’t usually think of anger and resentment the way we think about drugs or alcohol. But growing evidence suggests that, for many people, the craving for revenge follows the same patterns as ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

San Francisco is changing its approach to addressing drug addiction with a new policy emphasizing treatment. Why it matters: The city has for years been grappling with a deadly drug epidemic fueled ...

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart ...

Every day, drug and alcohol addiction shatters families, destabilizes neighborhoods, derails careers, and steals the lives of countless Americans. This National Alcohol and Drug Addiction Recovery ...